William Blair reiterated their outperform rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report issued ...

Research analysts at William Blair lowered their Q2 2026 earnings estimates for J.Jill in a report released on Thursday, ...

Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...

Software company DocuSign’s (DOCU) stock scored a rating upgrade from Hold to Buy from William Blair, thanks to the optimism ...

As Klarna wins installment lending for the retail giant's OnePay app, rival Affirm seeks to downplay the loss.

Palantir (NASDAQ:PLTR) was upgraded to Market Perform from Underperform by William Blair, following the recent share price decline by the data analysis and artificial intelligence software firm. "We ...

Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.

The embedded finance company, which posted a loss last year, hired Citigroup to explore its strategic options and named an ...

William Blair analyst Matthew Phipps last night upgraded Genmab (GMAB) to Outperform from Market Perform without a price target. after the ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

The note emphasized that Palantir shares declined 10% following a 4% selloff in the Nasdaq, and if the broader market ...